Search Count: 11
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-29 A.K.A 7-(1,2-Diphenylethyl)-1H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, CA, NAG, HEC, UEY, MAN |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-40 A.K.A 7-[(1R)-1-Phenyl-3-{[(1R,4R)-4-Phenylcyclohexyl]Amino}Propyl]-3H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: HEC, NAG, CA, CL, UFA |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-37 A.K.A 7-(1-Phenyl-3-(((1S,3S)-3-Phenyl-2,3-Dihydro-1H-Inden-1-Yl)Amino)Propyl)-1H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: HEC, CL, CA, UF7, NAG |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-41 A.K.A 7-[1-Phenyl-3-({4-Phenylbicyclo[2.2.2]Octan-1-Yl}Amino)Propyl]-3H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, HEC, NAG, CA, UFD |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-12 (Aka; 7-Benzyl-1H-[1,2,3]Triazolo[4,5-B]Pyrid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, NAG, FUC, HEC, BMA, MAN, 7GD, CA |
 |
Factor Xia In Complex With The Inhibitor Methyl ((10R,14S)- 14-(4-(3-Chloro-2,6-Difluorophenyl)-6-Oxo-3,6-Dihydro- 1(2H)-Pyridinyl)-10-Methyl-9-Oxo-8,16- Diazatricyclo[13.3.1.0~2,7~]Nonadeca-1(19),2,4,6,15,17- Hexaen-5-Yl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-06-10 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SWP, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(5E,8S)-8-[(6R)-6-(3-Chlorophenyl)-2-Oxo-1,3-Oxazinan-3-Yl]-2-Oxo-1,3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-09-18 Classification: HYDROLASE Ligands: NRJ, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(5E,8S)-8-[(4S)-4-(3-Chlorophenyl)-2-Oxopiperidin-1-Yl]-2-Oxo-1,3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2019-09-18 Classification: HYDROLASE Ligands: NR7, SO4, EDO |
 |
Factor Xa In Complex With The Inhibitor 1-(3'-Amino-1,2-Benzisoxazol-5'-Yl)-N-(4-(2'-((Dimethylamino)Methyl)-1H-Imidazol-1-Yl)-2-Fluorophenyl)-3-(Trifluoromethyl)-1H-Pyrazole-5-Carboxamide (Razaxaban; Dpc906; Bms-561389)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2006-03-28 Classification: HYDROLASE Ligands: IK8 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2000-07-03 Classification: TOXIN |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 1999-10-20 Classification: TOXIN Ligands: NBU |